10-(2-Substituted-amino-
ethyl)-10,11-dihydro-5-methylene-5H-debenzo[a,d]cycloheptenes
    12.
    发明授权
    10-(2-Substituted-amino- ethyl)-10,11-dihydro-5-methylene-5H-debenzo[a,d]cycloheptenes 失效
    10-(2-取代的 - 氨基 - 乙基)-10,11-二氢-5-亚甲基-5H-去苯并{8a,d {9环庚烯

    公开(公告)号:US3994961A

    公开(公告)日:1976-11-30

    申请号:US442078

    申请日:1974-02-13

    IPC分类号: C07C87/29

    摘要: 10-(2-substituted-aminoethyl)-10,11-dihydro-5-methylene-2 or 3 7 or 8-substituted or unsubstituted-5H-dibenzo[a,d]cycloheptenes e.g., 10-(2-dimethylaminoethyl)-10,11-dihydro-5-methylene-5H-dibenzo[a,d]cycloheptane, prepared by various methods including acid dehydration of the corresponding dibenzo[a,d]cycloheptene-5-ols. The compounds are useful as anti-depressants.

    摘要翻译: 10-(2-取代 - 氨基乙基)-10,11-二氢-5-亚甲基-2或3 7或8-取代或未取代的-5H-二苯并[a,d]环庚烯,例如10-(2-二甲基氨基乙基) 通过各种方法制备的10,11-二氢-5-亚甲基-5H-二苯并[a,d]环庚烷,包括相应的二苯并[a,d]环庚烯-5-醇的酸脱水。 该化合物可用作抗抑郁剂。

    2-Substituted-3-disubstituted-4,5,6,7-substituted or unsubstituted
phthalimidines
    17.
    发明授权
    2-Substituted-3-disubstituted-4,5,6,7-substituted or unsubstituted phthalimidines 失效
    2-取代的3-二取代-4,5,6,7-取代或未取代的苯二甲酰亚胺

    公开(公告)号:US3959269A

    公开(公告)日:1976-05-25

    申请号:US488041

    申请日:1974-07-12

    CPC分类号: C07D209/48 C07D209/46

    摘要: 2-Substituted-3-disubstituted-4,5,6,7-substituted or unsubstituted phthalimidines, e.g., 3-t-butyl-5-chloro-3-hydroxy-2-methylphthalimidine prepared by treating a substituted or unsubstituted N-substituted-2-lithiobenzamidelithium salts with a substituted acetylhalide. The compounds are useful as minor tranquilizers/sedative hypnotics.

    摘要翻译: 2-取代的3-二取代-4,5,6,7-取代或未取代的苯二甲酰亚胺,例如通过处理取代或未取代的N-取代的3-叔丁基-5-氯-3-羟基-2-甲基对苯二甲酰亚胺 -2-二硫代苯甲酰胺锂盐与取代的乙酰卤。 这些化合物可用作微量镇静剂/镇静催眠药。

    Isoxazolyl indolamines as intermediates
    18.
    发明授权
    Isoxazolyl indolamines as intermediates 失效
    异恶唑基吲哚胺作为中间体

    公开(公告)号:US4453001A

    公开(公告)日:1984-06-05

    申请号:US524995

    申请日:1983-08-22

    CPC分类号: C07D261/08

    摘要: This disclosure describes compounds of the formula ##STR1## wherein R.sub.1 represents hydrogen, fluoro, chloro, lower alkyl having 1 to 4 carbon atoms, or lower alkoxy having 1 to 4 carbon atoms, andR.sub.2 represents lower alkyl or ##STR2## where R.sub.5 represents hydrogen, fluoro, chloro, lower alkyl or lower alkoxy, andR.sub.3 and R.sub.4 each independently represent lower alkyl as defined above, andR.sub.3 and R.sub.4 together with N represent ##STR3## or pharmaceutically acceptable acid addition salts thereof, which are useful as anti-diabetic agents.

    摘要翻译: 本公开内容描述了下式的化合物,其中R 1表示氢,氟,氯,具有1至4个碳原子的低级烷基或具有1至4个碳原子的低级烷氧基,R 2表示低级烷基或者其中R 5表示 氢,氟,氯,低级烷基或低级烷氧基,并且R 3和R 4各自独立地表示如上定义的低级烷基,并且R 3和R 4与N一起代表其或其药学上可接受的酸加成盐, 糖尿病药。

    Isoxazolyl benzamides
    20.
    发明授权
    Isoxazolyl benzamides 失效
    异恶唑基苯甲酰胺

    公开(公告)号:US4112108A

    公开(公告)日:1978-09-05

    申请号:US747772

    申请日:1976-12-06

    申请人: Jeffrey Nadelson

    发明人: Jeffrey Nadelson

    IPC分类号: C07D261/08 A61K31/42

    CPC分类号: C07D261/08

    摘要: This disclosure describes compounds of the formula ##STR1## where R.sub.1 is straight chain alkyl, andR.sub.2 is hydrogen, halo having an atomic weight of about 19 to 36, lower alkoxy or trifluoromethyl,Which are useful as minor tranquilizers and sleep inducers.

    摘要翻译: 本公开内容描述了式(Ia)的化合物,其中R 1是直链烷基,R 2是氢,原子量约为19至36的卤素,低级烷氧基或三氟甲基,作为少量转化剂和休眠诱导剂有用。